{"id":"https://openalex.org/W2120928958","doi":null,"title":"Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer.","display_name":"Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer.","alternate_titles":[],"publication_year":2007,"publication_date":"2007-07-01","ids":{"openalex":"https://openalex.org/W2120928958","mag":"2120928958","pmid":"https://pubmed.ncbi.nlm.nih.gov/17695509"},"language":"en","primary_location":{"id":"pmid:17695509","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17695509","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2120928958"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079989633","display_name":"Masanori Tsujie","orcid":"https://orcid.org/0000-0002-1265-3397","observed_orcids":["https://orcid.org/0000-0002-1265-3397"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masanori Tsujie","raw_affiliation_strings":["Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University E2, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University E2, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014204252","display_name":"Shoji Nakamori","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shoji Nakamori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080581587","display_name":"Shin Nakahira","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shin Nakahira","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040965828","display_name":"Yuji K. Takahashi","orcid":"https://orcid.org/0000-0003-2394-2386","observed_orcids":["https://orcid.org/0000-0003-2394-2386"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuji Takahashi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103687731","display_name":"Nobuyasu Hayashi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nobuyasu Hayashi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061233614","display_name":"Jiro Okami","orcid":"https://orcid.org/0000-0002-7633-9700","observed_orcids":["https://orcid.org/0000-0002-7633-9700"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiro Okami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110385545","display_name":"Hiroaki Nagano","orcid":"https://orcid.org/0000-0002-2828-0951","observed_orcids":["https://orcid.org/0000-0002-2828-0951"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroaki Nagano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110815452","display_name":"Keizo Dono","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keizo Dono","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112619541","display_name":"Koji Umeshita","orcid":"https://orcid.org/0000-0002-5958-4827","observed_orcids":["https://orcid.org/0000-0002-5958-4827"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koji Umeshita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059872605","display_name":"Masato Sakon","orcid":"https://orcid.org/0000-0002-2703-3385","observed_orcids":["https://orcid.org/0000-0002-2703-3385"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masato Sakon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108403721","display_name":"Morito Monden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Morito Monden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5977,"has_fulltext":false,"cited_by_count":73,"citation_normalized_percentile":{"value":0.82659909,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"27","issue":"4B","first_page":"2241","last_page":"2249"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.7074999809265137,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.7074999809265137,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.09109999984502792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.06210000067949295,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hent1","display_name":"hENT1","score":0.9890000224113464},{"id":"https://openalex.org/keywords/5-fluorouracil-resistance","display_name":"5-fluorouracil resistance","score":0.9760000109672546},{"id":"https://openalex.org/keywords/gemcitabine-resistance","display_name":"gemcitabine resistance","score":0.9869999885559082},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chemosensitivity-biomarker","display_name":"chemosensitivity biomarker","score":0.6970000267028809},{"id":"https://openalex.org/keywords/thymidylate-synthase","display_name":"thymidylate synthase","score":0.9760000109672546},{"id":"https://openalex.org/keywords/dihydropyrimidine-dehydrogenase","display_name":"dihydropyrimidine dehydrogenase","score":1.0},{"id":"https://openalex.org/keywords/pancreatic-cancer-cell-lines","display_name":"pancreatic cancer cell lines","score":0.7070000171661377}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9283093214035034},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.7206597328186035},{"id":"https://openalex.org/C123321153","wikidata":"https://www.wikidata.org/wiki/Q22676802","display_name":"Thymidylate synthase","level":4,"score":0.7030631303787231},{"id":"https://openalex.org/C2777844706","wikidata":"https://www.wikidata.org/wiki/Q422504","display_name":"Deoxycytidine","level":4,"score":0.6552099585533142},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.6067731380462646},{"id":"https://openalex.org/C2778050828","wikidata":"https://www.wikidata.org/wiki/Q1114455","display_name":"Dihydropyrimidine dehydrogenase","level":5,"score":0.6044714450836182},{"id":"https://openalex.org/C2779268695","wikidata":"https://www.wikidata.org/wiki/Q14914175","display_name":"Deoxycytidine kinase","level":5,"score":0.582412838935852},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.5591170191764832},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.539996325969696},{"id":"https://openalex.org/C2780549722","wikidata":"https://www.wikidata.org/wiki/Q7068260","display_name":"Nucleoside transporter","level":4,"score":0.5131965279579163},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5072571635246277},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4316455125808716},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4282796382904053},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.42071184515953064},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41041794419288635},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3932955861091614},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37370729446411133},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.19145888090133667},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1183168888092041},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1104215681552887}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D033721","descriptor_name":"Equilibrative Nucleoside Transporter 1","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D033721","descriptor_name":"Equilibrative Nucleoside Transporter 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D033721","descriptor_name":"Equilibrative Nucleoside Transporter 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048708","descriptor_name":"Cell Growth Processes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17695509","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17695509","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:2120928958","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17695509","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W55408953","https://openalex.org/W1498281658","https://openalex.org/W1751651908","https://openalex.org/W1797303364","https://openalex.org/W1905254767","https://openalex.org/W1931508686","https://openalex.org/W1963925513","https://openalex.org/W1965195700","https://openalex.org/W1967675162","https://openalex.org/W1971928019","https://openalex.org/W1984328540","https://openalex.org/W1985268469","https://openalex.org/W1994411692","https://openalex.org/W1999653639","https://openalex.org/W2000465781","https://openalex.org/W2000932071","https://openalex.org/W2010198833","https://openalex.org/W2021333778","https://openalex.org/W2023040959","https://openalex.org/W2040065840","https://openalex.org/W2049290799","https://openalex.org/W2050072674","https://openalex.org/W2055142365","https://openalex.org/W2061797905","https://openalex.org/W2069487731","https://openalex.org/W2090137771","https://openalex.org/W2116846790","https://openalex.org/W2117569814","https://openalex.org/W2120764182","https://openalex.org/W2131025996","https://openalex.org/W2131555383","https://openalex.org/W2155703416","https://openalex.org/W2159441446","https://openalex.org/W2161769699","https://openalex.org/W2167553569","https://openalex.org/W2171508453","https://openalex.org/W2429811587"],"related_works":["https://openalex.org/W2019084905","https://openalex.org/W1968323734","https://openalex.org/W2504069044","https://openalex.org/W2360188668","https://openalex.org/W2084058063","https://openalex.org/W2616171551","https://openalex.org/W3031725733","https://openalex.org/W2412099015","https://openalex.org/W2149076440","https://openalex.org/W3095342412"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,26,96],"purpose":[2],"of":[3,37,56,89,99,108],"this":[4],"study":[5],"was":[6,51,73,83,128,148,156],"to":[7,12,85,189],"find":[8],"a":[9,186],"novel":[10],"biomarker":[11],"predict":[13,190],"5-fluorouracil":[14],"(5-FU)":[15],"or":[16,132],"gemcitabine":[17,31,79,118,144],"(2',2'-difluoro-deoxycytidine)":[18],"sensitivity":[19,32,155,192],"in":[20,110,120,176,193],"pancreatic":[21,58,194],"cancer.":[22,195],"MATERIALS":[23],"AND":[24],"METHODS:":[25],"relationship":[27],"between":[28,130],"5-FU":[29,109,137,154,177,191],"and":[30,33,47,68,114,136,153,179],"the":[34,87,105,140,160],"mRNA":[35,71,101,134,182],"levels":[36,98,135,183],"human":[38,57],"equilibrative":[39],"nucleoside":[40],"transporter":[41],"1":[42],"(hENT1),":[43],"thymidylate":[44],"synthase":[45],"(TS)":[46],"dihydropyrimidine":[48],"dehydrogenase":[49],"(DPD)":[50],"investigated":[52],"using":[53],"seven":[54,112],"types":[55],"carcinoma":[59],"cell":[60],"line":[61],"(AsPC1,":[62],"BxPC3,":[63],"MiaPaCa-2,":[64],"PSN1,":[65],"Panc1,":[66],"PCI6,":[67],"KMP-4).":[69],"Quantitative":[70],"expression":[72,97],"measured":[74],"by":[75,91,151],"LightCycler.":[76],"A":[77],"[3H]":[78,143],"cellular":[80],"uptake":[81,145],"assay":[82],"performed":[84],"examine":[86],"inhibition":[88],"hENT1":[90,100,147,171,181],"nitrobenzylmercaptoprine":[92],"ribonucleoside":[93],"(NBMPR).":[94],"RESULTS:":[95],"significantly":[102,149,157],"correlated":[103,116],"with":[104,117,164],"IC50":[106],"value":[107],"all":[111],"lines":[113,122],"also":[115],"resistance":[119,178],"six":[121],"(except":[123],"AsPC1).":[124],"No":[125],"significant":[126],"association":[127],"observed":[129],"TS":[131],"DPD":[133],"sensitivity.":[138],"In":[139],"PSN1":[141],"cells,":[142],"via":[146],"inhibited":[150],"NBMPR,":[152],"increased":[158],"when":[159],"cells":[161],"were":[162],"pretreated":[163],"NBMPR.":[165],"CONCLUSION:":[166],"Our":[167],"results":[168],"suggest":[169],"that":[170,180],"plays":[172],"an":[173],"important":[174],"role":[175],"might":[184],"be":[185],"useful":[187],"marker":[188]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2120928958","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
